Company Filing History:
Years Active: 2014
Title: The Innovations of Soo S Koo
Introduction
Soo S Koo is a notable inventor based in Hockessin, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. His work is essential in advancing treatments for various diseases.
Latest Patents
Soo S Koo holds a patent for "Substituted 3-phenyl-1,2,4-Oxadiazole compounds." This patent discloses compounds of Formula (I) or their stereoisomers, salts, or prodrugs. The compounds are characterized by specific groups, where R1 and R2 can be independently C-Calkyl, or they can form a cyclic group with the carbon atom to which they are attached. The compounds are designed to act as selective agonists for the G protein-coupled receptor S1P1. They are particularly useful in treating, preventing, or slowing the progression of autoimmune diseases and chronic inflammatory diseases.
Career Highlights
Soo S Koo is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to contribute to innovative therapeutic solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Jagabandhu Das and Anurag S Srivastava. Their collaborative efforts in research and development have further enhanced the impact of their work in the pharmaceutical industry.
Conclusion
Soo S Koo's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments.